← Back to Search

Dietary Supplement

Oral Nutraceutical Supplement for Alopecia

N/A
Waitlist Available
Research Sponsored by DeNova Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 90, 180, 270, 360
Awards & highlights

Study Summary

Hair loss study in men with self-perceived thinning hair and loss

Eligible Conditions
  • Alopecia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 90, 180, 270, 360
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 90, 180, 270, 360 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hair counts
Secondary outcome measures
Hair density
Shaft Thickness

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Oral Nutraceutical SupplementActive Control1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

DeNova ResearchLead Sponsor
21 Previous Clinical Trials
1,333 Total Patients Enrolled
1 Trials studying Alopecia
40 Patients Enrolled for Alopecia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss
2018. "Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03709563.
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top